We tell investment stories for great teams and technologies
Oyster is an advisory and execution firm supporting healthcare science and technology innovators with the securing of next stage investments in their businesses whilst optimising exit strategies
What We Do
Oyster provides hands-on support for early to mid-stage life science and healthcare companies with preparation and execution of their investment raising strategies. We support our clients with investor-ready business planning, collateral development, pre-qualified investor matching, direct introductions, transaction development and deal process support.
We support companies across the globe with raising their Seed to Series-A/B investments, whilst guiding businesses with strategies to maximise exit investment returns. Oyster is a investment advisor for the UK Department for International Trade, supporting their prospective FDI clients from all over the world with investment to enable their foreign direct investment in the UK.
Our Services
COLLATERAL
‘No second chance to make
a great first impression.’
For entrepreneurs and their world-class technologies, Oyster maximises investment opportunities by ensuring collateral is at an investor-ready standard.
INVESTOR
‘The only impossible journey
is the one never begun.’
Oyster identifies, qualifies and introduces novel technology companies to Seed to Series-A/B investors across the globe.
INVESTMENT
‘Neither one of us is more
capable than all of us.’
From investor engagement to transaction development to due diligence, to data valuation, and deal closure, Oyster actively supports its clients end-to-end.
DATA VALUATIONS
‘Your data has a certain value and you need to understand what this is in order to make appropriate investment decisions to support your data’
To understand the value of your data you need a methodology for data valuation and a means of calculating it. Our proven process enables you to work out what the actual value of your data is and leverage that value.
Our Focus
Our Approach
Client onboarding
In-depth business strategy, scientific roadmap
and collateral review to
optimise investment
propositions.
Investment preparation
Investor ready collateral
creation, ensuring investor
due diligence is assessed
ahead of a discussion.
Investor search
Technology and investor
matching against 10,000+ global life science /
healthcare investor base.
Marketing campaign
Digital marketing delivering
real-time analytics to enable decision support on a range of campaign strategies.
Legal / Due diligence
Support through the legal
and due diligence process,
term sheet review and deal
closures support.
Post Deal Support
Post-deal mobilisation management, strategy road mapping and next phase investment support.